Clinical Trial Update: Avonex®: Safety, Blood Levels and Effects [Phase 1]

View source ↗

Summary

Phase 1 study of Avonex (interferon beta-1a) in multiple sclerosis reports safety, pharmacokinetics (blood levels), and observed effects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Avonex (Interferon beta-1a)

Snippet

Sponsor: Trio Medicines Ltd. | Conditions: Multiple Sclerosis (MS) | Phase 1 | Status: COMPLETED